Table 1 Histopathological findings and cancer staging in 112 women detected to have primary ovarian malignancy
Total (n= 112) | Premenopausal (n=49) | Postmenopausal (n= 63) | |
|---|---|---|---|
Pathology, n (%) | |||
Serous | 66 (58.92%) | 24 (48.97%) | 42 (66.66%) |
Mucinous | 29 (25.89%) | 11 (22.44%) | 18 (28.57%) |
Endometroid | 6 (5.35%) | 4 (8.1%) | 2 (3.17%) |
Clear cell | 1 (0.89%) | 1 (2.04%) | |
Germ cell | 7 (6.25%) | 7 (14.28%) | |
Leiomyosarcoma ovary | 1 (0.89%) | 1 (2.04%) | |
SCT & GCT SP ovary | 1 (0.89%) | 1 (2.04%) | |
Carcinoid tumor | 1 (0.89%) | 1 (1.58%) | |
Stage, n (%) | |||
I | 29 (25.89%) | 15 (30.61%) | 14 (22.22%) |
II | 19 (16.96%) | 6 (12.24%) | 13 (20.63%) |
III | 52 (46.42%) | 23 (46.93%) | 29 (46.03%) |
IV | 12 (10.71%) | 5 (10.20%) | 7 (11.11%) |